Page 167 - IJB-10-2

International Journal of Bioprinting dECM bioink for in vitro disease modeling

137. Lancaster MA, Renner M, Martin C-A, et al. Cerebral 150. Potjewyd G, Moxon S, Wang T, Domingos M, Hooper
organoids model human brain development and NM. Tissue engineering 3D neurovascular units: a
microcephaly. Nature. 2013;501(7467):373-379. biomaterials and bioprinting perspective. Trends Biotechnol.
doi: 10.1038/nature12517 2018;36(4):457-472.
doi: 10.1016/j.tibtech.2018.01.003
138. Saha K, Keung AJ, Irwin EF, et al. Substrate modulus directs
neural stem cell behavior. Biophys J. 2008;95(9):4426-4438. 151. Mossink B, Verboven AH, van Hugte EJ, et al. Human
doi: 10.1529/biophysj.108.132217 neuronal networks on micro-electrode arrays are a highly
robust tool to study disease-specific genotype-phenotype
139. Yi B, Xu Q, Liu W. An overview of substrate stiffness guided correlations in vitro. Stem Cell Rep. 2021;16(9):2182-2196.
cellular response and its applications in tissue regeneration. doi: 10.1016/j.stemcr.2021.07.001
Bioact Mater. 2022;15:82-102.
doi: 10.1016/j.bioactmat.2021.12.005 152. Nabel EG. Cardiovascular disease. N Engl J Med. 2003;
349(1):60-72.
140. Portenoy RK. Cancer pain: pathophysiology and syndromes. doi: 10.1056/NEJMra035098
Lancet. 1992;339(8800):1026-1031.
doi: 10.1016/0140-6736(92)90545-e 153. Wilkins E, Wilson L, Wickramasinghe K, et al. European
Cardiovascular Disease Statistics 2017. Brussels, Belgium:
141. Yi H-G, Jeong YH, Kim Y, et al. A bioprinted human- European Heart Network; 2017.
glioblastoma-on-a-chip for the identification of patient- https://researchportal.bath.ac.uk/en/publications/
specific responses to chemoradiotherapy. Nat Biomed Eng. european-cardiovascular-disease-statistics-2017
2019;3(7):509-519.
doi: 10.1038/s41551-019-0363-x 154. Zhang WJ, Liu W, Cui L, Cao Y. Tissue engineering of blood
vessel. J Cell Mol Med. 2007;11(5):945-957.
142. Park W, Bae M, Hwang M, Jang J, Cho D-W, Yi doi: 10.1111/j.1582-4934.2007.00099.x
H-G. 3D cell-printed hypoxic cancer-on-a-chip for
recapitulating pathologic progression of solid cancer. JoVE. 155. Abramson DI. Blood Vessels and Lymphatics. Cambridge,
2021;(167):e61945. Massachusetts, USA: Elsevier; 2013.
doi: 10.3791/61945 doi: 10.1016/C2013-0-12391-4
156. Bogseth A, Ramirez A, Vaughan E, Maisel K. In vitro models
143. Slanzi A, Iannoto G, Rossi B, Zenaro E, Constantin G. In of blood and lymphatic vessels—connecting tissues and
vitro models of neurodegenerative diseases. Front Cell Dev immunity. Adv Biol. 2023;7(5):2200041.
Biol. 2020;8:328. doi: 10.1002/adbi.202200041
doi: 10.3389/fcell.2020.00328
157. Abdelsayed G, Ali D, Malone A, et al. 2D and 3D in-vitro
144. Cetin S, Knez D, Gobec S, Kos J, Pišlar A. Cell models for models for mimicking cardiac physiology. Appl Eng Sci.
Alzheimer’s and Parkinson’s disease: at the interface of biology 2022;12:100115.
and drug discovery. Biomed Pharmacother. 2022;149:112924. doi: 10.1016/j.apples.2022.100115
doi: 10.1016/j.biopha.2022.112924
158. Ferri N, Siegl P, Corsini A, Herrmann J, Lerman A,
145. Osaki T, Shin Y, Sivathanu V, Campisi M, Kamm RD. In Benghozi R. Drug attrition during pre-clinical and clinical
vitro microfluidic models for neurodegenerative disorders. development: understanding and managing drug-induced
Adv Healthc Mater. 2018;7(2):1700489. cardiotoxicity. Pharmacol Ther. 2013;138(3):470-484.
doi: 10.1002/adhm.201700489 doi: 10.1016/j.pharmthera.2013.03.005
146. Kong JS, Huang X, Choi YJ, et al. Promoting long‐term 159. Ho D, Zhao X, Gao S, Hong C, Vatner DE, Vatner SF. Heart
cultivation of motor neurons for 3D neuromuscular junction rate and electrocardiography monitoring in mice. Curr
formation of 3D in vitro using central‐nervous‐tissue‐ Protoc Mouse Biol. 2011;1(1):123-139.
derived bioink. Adv Healthc Mater. 2021;10(18):2100581. doi: 10.1002/9780470942390.mo100159
doi: 10.1002/adhm.202100581
160. Wolfe JT, He W, Kim M-S, et al. 3D-bioprinting of patient-
147. Kim W, Kim G. Bioprinting 3D muscle tissue supplemented derived cardiac tissue models for studying congenital heart
with endothelial-spheroids for neuromuscular junction disease. Front Cardiovasc Med. 2023;10:1162731.
model. Appl Phys Rev. 2023;10(3):031410. doi: 10.3389/fcvm.2023.1162731
doi: 10.1063/5.0152924
161. Faulkner-Jones A, Zamora V, Hortigon-Vinagre MP, et
148. Lee SJ, Esworthy T, Stake S, et al. Advances in 3D bioprinting al. A bioprinted heart-on-a-chip with human pluripotent
for neural tissue engineering. Adv Biosyst. 2018;2(4):1700213. stem cell-derived cardiomyocytes for drug evaluation.
doi: 10.1002/adbi.201700213 Bioengineering. 2022;9(1):32.
doi: 10.3390/bioengineering9010032
149. Daneman R, Prat A. The blood–brain barrier. Cold Spring
Harb Perspect Biol. 2015;7(1):a020412. 162. Das S, Kim S-W, Choi Y-J, et al. Decellularized extracellular
doi: 10.1101/cshperspect.a020412 matrix bioinks and the external stimuli to enhance cardiac

Volume 10 Issue 2 (2024) 159 doi: 10.36922/ijb.1970